Jordi Jornet-Plaza
@jordijornet.bsky.social
PhD student in Neuropharmacology Research Group🧠 at @uib.cat
Reposted by Jordi Jornet-Plaza
#PublicaSalutIB 🐀💊 @jordijornet.bsky.social , @sandracorvi.bsky.social i @garciafusterlab.bsky.social de @idisba.bsky.social han publicat la caracterització de l'ús terapèutic de la ketamina en rates adolescents https://www.infosalut.com/17236 https://doi.org/10.1016/j.biopha.2024.117781
March 20, 2025 at 10:10 AM
#PublicaSalutIB 🐀💊 @jordijornet.bsky.social , @sandracorvi.bsky.social i @garciafusterlab.bsky.social de @idisba.bsky.social han publicat la caracterització de l'ús terapèutic de la ketamina en rates adolescents https://www.infosalut.com/17236 https://doi.org/10.1016/j.biopha.2024.117781
Reposted by Jordi Jornet-Plaza
Here is the link to "Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile": our latest publication with @jordijornet.bsky.social as first author: www.sciencedirect.com/science/arti...
Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile
While ketamine was approved for treatment-resistant depression in adult patients, its efficacy and safety profile for adolescence still requires furth…
www.sciencedirect.com
December 25, 2024 at 5:24 AM
Here is the link to "Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile": our latest publication with @jordijornet.bsky.social as first author: www.sciencedirect.com/science/arti...
Reposted by Jordi Jornet-Plaza
Celebrating a year full of accomplishments with these great bunch of people. Happy holidays 🙂
December 22, 2024 at 5:13 AM
Celebrating a year full of accomplishments with these great bunch of people. Happy holidays 🙂
Reposted by Jordi Jornet-Plaza
Safety concerns following the use of ketamine as a potential antidepressant for adolescent rats of both sexes https://www.biorxiv.org/content/10.1101/2024.11.08.622617v1
Safety concerns following the use of ketamine as a potential antidepressant for adolescent rats of both sexes https://www.biorxiv.org/content/10.1101/2024.11.08.622617v1
While ketamine is already approved for treatment resistant depression in adult patients, its efficac
www.biorxiv.org
November 11, 2024 at 6:01 PM
Safety concerns following the use of ketamine as a potential antidepressant for adolescent rats of both sexes https://www.biorxiv.org/content/10.1101/2024.11.08.622617v1